Supernus Pharmaceuticals
SUPN
SUPN
237 hedge funds and large institutions have $1.57B invested in Supernus Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 84 increasing their positions, 94 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $1.72B → $1.57B (-$151M)
11% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 94
27% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 30
Holders
237
Holding in Top 10
3
Calls
$611K
Puts
$52K
Top Buyers
| 1 | +$7.91M | |
| 2 | +$6.82M | |
| 3 | +$6.05M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$4.14M |
| 5 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$4.06M |
Top Sellers
| 1 | -$12.4M | |
| 2 | -$5.24M | |
| 3 | -$3.2M | |
| 4 |
BC
Burney Company
Reston,
Virginia
|
-$3.16M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$2.67M |